Immunoglobulins are Y-shaped molecules made up of sugar and protein produced by plasma cells, a type of white blood cell. They have three main functions: neutralizing foreign invaders to prevent ...

Mediar Therapeutics has dosed the first subject in the Phase II WISPer trial of its investigational therapy, MTX-463, for ...

A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic ...

The global human immunoglobulin market is projected to rise by $9.7b through 2028 at an estimated compound annual growth rate (CAGR) of 10.11%, according to Technavio. The sector’s expansion is ...

SAB-142 is a first-in-class fully-human anti-thymocyte immunoglobulin being developed as a disease-modifying treatment to delay the onset and progression of T1D. In October 2023, SAB received ...

Researchers have analyzed the antibody Immunoglobulin M in ... perspective and implies that fish IgM and human IgM can bind antigens and function differently." It is unclear why the joining ...